Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Nov 4, 2025 · Filed Nov 6, 2025
A board member of Calix sold $25.3M of Calix shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$25,280,000
Shares × reported transaction price
6 days after results of Oct 29, 2025, 85 days before results of Jan 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Filing box checked: sold under a Rule 10b5-1 plan
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −8.3% | +0.1% | −8.5% |
| 30 days | −14.3% | +1.9% | −16.2% |
| 90 days | −20.9% | +1.0% | −21.9% |
| 180 days | −30.8% | +9.4% | −40.1% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.